Navigation Links
Monoclonal antibody effective against norovirus
Date:7/24/2013

Researchers from the National Institute of Allergy and Infectious Diseases (NIAID) provide the first proof of concept data showing that a monoclonal antibody can neutralize human norovirus. This research, which could one day lead to effective therapies against the virus, was published online ahead of print in the Journal of Virology.

"We initiated this work because there is presently no virus-specific treatment or vaccine to control the norovirus illness," says Kim Y. Green, a researcher on the study. "Our working hypothesis was that a highly specific norovirus antibody that binds to the outer surface of the virus particle might prevent the ability of the virus to infect susceptible host cells."

The team first isolated genes from chimpanzee immune cells encoding norovirus-specific antibodies. They then converted these into human-compatible full-length immunoglobulin molecules. They successfully tested two of the antibodies against norovirus infection in chimpanzees.

"An effective therapeutic antibody might be explored as both a treatment for norovirus gastroenteritis, and as a disease prevention strategy," says Green. "Consider a developing outbreak scenario in which food-handlers, healthcare workers, deployed military, or travelers could reduce risk of infection, incapacitation, and spread if a safe and inexpensive treatment is immediately available."

Norovirus causes roughly 20 million cases of acute diarrhea and vomiting annually in the US, alone, according to the US Centers for Disease Control and Prevention (CDC). While in most people, symptoms last a day or two, for those with impaired immune systems, and the young and the aged, norovirus can be life-threatening. It is responsible for an estimated 70,000 hospitalizations and 800 deaths annually, and roughly one in 15 Americans get the disease every year. It is unusually contagious, via the fecal-oral route. People who have had norovirus remain highly contagio
'/>"/>

Contact: Jim Sliwa
jsliwa@asmusa.org
202-942-9297
American Society for Microbiology
Source:Eurekalert

Page: 1 2

Related medicine news :

1. New monoclonal antibody inhibits tumor growth in advanced solid tumors in phase I clinical trial
2. Monoclonal antibody appears effective and safe in asthma Phase IIa trial
3. Monoclonal Antibodies Market - New Industry Research Report is Now Available for Pre-Order at Transparency Market Research
4. Monoclonal Antibodies Market Dealmaking in Biopharma Industry Analyzed in New Research Report at ReportsnReports.com
5. Antibody therapy prevents gastrointestinal damage following radiation exposure in mice
6. Scientists Pinpoint Antibody That May Be Specific to MS Patients
7. NIH scientists map first steps in flu antibody development
8. Elevated Antibody Levels May Predict Rheumatoid Arthritis Risk
9. Antibody-coated stents: Indication of disadvantages
10. Evolution in the antibody factory
11. Scientists ID Antibody That Might Boost Cancer Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... 20, 2014 BCC Research ( ... PHOTONIC SENSORS AND DETECTORS: TECHNOLOGIES AND GLOBAL MARKETS ... is expected to grow to $15.2 billion by ... (CAGR) of 15.9%. Increasing industrialization is driving ... a rapidly expanding range of industrial applications such ...
(Date:8/20/2014)... A Missouri federal judge has remanded a lawsuit filed ... GranuFlo and NaturaLyte to the City of St. Louis Circuit ... The judge rejected an assertion by the defendants that the ... et al. v. Fresenius Medical Care North America Inc., et ... the manufacturer of the dialysis products GranuFlo and NaturaLyte. In ...
(Date:8/20/2014)... (HealthDay News) -- Leaving the car at home and getting ... for your health, a new study indicates. Researchers looked ... that 76 percent of men and 72 percent of women ... of women used public transit, and 14 percent of men ... who drove to work weighed more and had higher levels ...
(Date:8/20/2014)... (PRWEB) August 20, 2014 The ... leading nonprofit authority on the use of health ... announced the full agenda for its annual fall ... IT Efficiency. WEDI-Con 2014 will take place at ... 20-23, 2014, attracting a diverse cross-section of payers, ...
(Date:8/20/2014)... Parents and kids across the nation are ... means buying textbooks and arranging after school care, there ... part of the annual re-commitment to your child’s education; ... Association, 27% of students say they experience "extreme stress" ... are stressed by school pressures. The study, Stress in ...
Breaking Medicine News(10 mins):Health News:Global Market for Photonic Sensors and Detectors to Reach $15.2 Billion in 2019 2Health News:Global Market for Photonic Sensors and Detectors to Reach $15.2 Billion in 2019 3Health News:GranuFlo/NaturaLyte Case Remanded to State Court By Missouri Federal Judge, Baron and Budd Reports 2Health News:Want to Stay Slim? Leave the Car at Home 2Health News:WEDI Releases Full Conference Agenda for Its Annual Fall Conference – WEDI-Con 2014 2Health News:WEDI Releases Full Conference Agenda for Its Annual Fall Conference – WEDI-Con 2014 3Health News:Five Easy Steps to Help Your Child Manage Back-to-school Stress 2Health News:Five Easy Steps to Help Your Child Manage Back-to-school Stress 3
... Resuscitating hopelessly ill patients too slowly to save their ... prolongs death and suffering, according to the November issue ... Jacinta Kelly, from Trinity College Dublin, has called for ... the practice of slow codes and highlighted the need ...
... Ellex Medical Lasers,Limited (ASX: ELX), a global leader ... ultrasound systems, announced today that the initial,results of ... be presented by Peter Hamilton MD, FRCOph at ... which takes place,November 10-13, in New Orleans. Dr. ...
... Amira Pharmaceuticals, a small,molecule pharmaceutical company focused on ... disease linked to the eicosanoid pathway,today announced the ... development. Dr. Raizon-Ounis brings 20 years of ... clinical research & licensing executive with,Roche Palo Alto. ...
... convenience for on-the-go snacking, COLUMBUS, Ohio, ... ),today announced the launch of new Fruitified(TM) ... four,great-tasting flavors: Apple Cinnamon, Blueberry, Banana Nut ... an excellent source of,protein and calcium and ...
... play role in autism, asthma,and other chronic health ... National Autism,Association (NAA) announced today a nationwide initiative ... program created by,the Deirdre Imus Environmental Center for ... to eliminate the serious,dangers posed to children from ...
... to the Third Quarter of 2006- ... During the Quarter-, PRINCETON, N.J., Nov. 1 Orchid ... identity DNA testing,services, today reported its financial results for the ... the third quarter of 2007,compared to $15.7 million for the ...
Cached Medicine News:Health News:Token resuscitation attempts on hopelessly ill patients prolong suffering 2Health News:Token resuscitation attempts on hopelessly ill patients prolong suffering 3Health News:Ellex Announces New Retina Regeneration Therapy to be Presented at the AAO 2Health News:Ellex Announces New Retina Regeneration Therapy to be Presented at the AAO 3Health News:Ellex Announces New Retina Regeneration Therapy to be Presented at the AAO 4Health News:Amira Pharmaceuticals Appoints First Vice President of Development 2Health News:Abbott Launches Fruitified(TM) ZonePerfect(R) All-Natural Nutrition Bars 2Health News:Abbott Launches Fruitified(TM) ZonePerfect(R) All-Natural Nutrition Bars 3Health News:National Autism Association and Deirdre Imus Environmental Center for Pediatric Oncology Announce National 'Greening Your School' Initiative 2Health News:Orchid Cellmark Reports Third Quarter 2007 Financial Results 2Health News:Orchid Cellmark Reports Third Quarter 2007 Financial Results 3Health News:Orchid Cellmark Reports Third Quarter 2007 Financial Results 4Health News:Orchid Cellmark Reports Third Quarter 2007 Financial Results 5Health News:Orchid Cellmark Reports Third Quarter 2007 Financial Results 6Health News:Orchid Cellmark Reports Third Quarter 2007 Financial Results 7
(Date:8/19/2014)... , Aug. 19, 2014  Boehringer Ingelheim today ... (FDA) accepted for review the New Drug Application ... and olodaterol delivered via the Respimat ® ... maintenance treatment of airflow obstruction in patients with ... and/or emphysema. Tiotropium + olodaterol FDC will not ...
(Date:8/19/2014)... -- According to Kalorama Information, electronic medical records (EMR) ... in healthcare a reality, and this a factor that ... Recovery and Reinvestment Act, the U.S. government dedicated $20.6 ... will start applying soon for use of paper records.  ... of the EMR industry, EMR 2014: The Market ...
(Date:8/19/2014)... Calif. , Aug. 19, 2014  Cardiva Medical, ... two tranches of a $16.5 million Series 3 private ... with GE Capital. The Company will use the proceeds ... facility to expand commercial efforts for its VASCADE® Vascular ... . Investing in Series 3 private ...
Breaking Medicine Technology:Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 2Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 3Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 4Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 5Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 6Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 7Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 8Kalorama: EMR Paves the Way for Big Data 2Kalorama: EMR Paves the Way for Big Data 3Cardiva Medical, Inc. Announces Completion of the first two tranches of Series 3 Private Equity Financing and the Closing of a Senior Secured Debt Facility with GE Capital 2
... Nebulizer Prefilled 750ML Sterile H 2 O ... with sterile water for inhalation, these humidifier systems ... which makes a round opening for secure attachment ... designed to help prevent particulate from reaching oxygen ...
... 35%-100% FIO2, ,Empty Nebulizer 002002 has ... It has ports for a feed set ... 5007P and 5207 have FIO2 settings adjustable ... slip-on heaters are also available to provide ...
... , One device provides both ... from a single gas source , ... the number of SKUs dedicated to ... inconvenience of double or wye set ...
MISTY OX® Hi-Fi Nebulizer...
Medicine Products: